Inventor
Martina Schäfer
Inventor
Berlin, DE
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes21%
C07KPeptides6%
C07BGeneral methods of organic chemistry4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
11,046,783Antibodies capable of binding to the coagulation factor XIa and uses thereof202110,722,501Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof202010,300,062Bicyclically substituted uracils and the use thereof201910,221,247Antibodies capable of binding to the coagulation factor XIa and uses thereof201910,183,932Substituted oxopyridine derivatives and use thereof cardiovascular disorders201910,138,236Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives201810,077,265Substituted oxopyridine derivatives201810,040,866Nucleic acids and host cells expressing antibodies capable of binding to the coagulation factor XIa and uses thereof20189,949,978Bicyclically substituted uracils and the use thereof20189,951,086Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments20189,949,977Bicyclically substituted uracils and the use thereof20189,918,969'Substituted oxopyridine derivatives and use thereof as factor XIa/plasma'20189,822,102'Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders'20179,783,614'Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor Xia and uses thereof'20179,765,070'Substituted oxopyridine derivatives'20179,751,843'Substituted uracils and use thereof'20179,481,672'Bicyclically substituted uracils and the use thereof'20169,475,809'Substituted oxopyridine derivatives and use thereof as factor xia/plasma'20169,434,690'Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders'20167,598,260'CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents'20097,504,410'Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents'20097,291,624'CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents'20077,235,561'Compound and a composition including such a compound'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2009Patents assigned to BAYER SCHERING PHARMA AG (2)· patent assignee history
2007–2009Patents assigned to SCHERING AG (2)· patent assignee history
2007–2021Based in Berlin, DE· patent location history
2016–2021Patents assigned to Bayer Pharma AG (19)· patent assignee history
2020Patents assigned to BAYER AG (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| Bayer Pharma AG | 19 | 2016–2021 |
| BAYER SCHERING PHARMA AG | 2 | 2007–2009 |
| SCHERING AG | 2 | 2007–2009 |
| BAYER AG | 1 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Berlin, DE | 23 | 2007–2021 |